eFFECTOR Therapeutics, Inc. (EFTR) vs Seelos Therapeutics, Inc. (SEELQ)
- eFFECTOR Therapeutics, Inc. EFTR 0.00 NaN
- Seelos Therapeutics, Inc. SEELQ 0.00 NaN
eFFECTOR Therapeutics, Inc. and Seelos Therapeutics, Inc. are both Biotechnology companies. Seelos Therapeutics, Inc. is the larger, with a market value of $700.0K against $200.0K — 3.5× the size. Seelos Therapeutics, Inc. grew revenue faster over the last twelve months: −51.5% against −86.2%. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Seelos Therapeutics, Inc. leads on 7 and eFFECTOR Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | EFTR | SEELQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (1,480.04%) | 0.00% |
| Net margin | 0.00% | 203.13% | 0.00% |
| Free cash flow margin | 0.00% | (659.09%) | 0.00% |
| Return on equity | 1,737.63% | (10.86%) | (56.36%) |
| Return on assets | (141.18%) | 57.34% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack